Picture of server farm and IT infrastructure

Where technology & law meet: Open Access research on data security & its regulation ...

Strathprints makes available Open Access scholarly outputs exploring both the technical aspects of computer security, but also the regulation of existing or emerging technologies. A research specialism of the Department of Computer & Information Sciences (CIS) is computer security. Researchers explore issues surrounding web intrusion detection techniques, malware characteristics, textual steganography and trusted systems. Digital forensics and cyber crime are also a focus.

Meanwhile, the School of Law and its Centre for Internet Law & Policy undertake studies on Internet governance. An important component of this work is consideration of privacy and data protection questions and the increasing focus on cybercrime and 'cyberterrorism'.

Explore the Open Access research by CIS on computer security or the School of Law's work on law, technology and regulation. Or explore all of Strathclyde's Open Access research...

Electrochemiluminescence platform for the detection of C-reactive proteins : application of recombinant antibody technology to cardiac biomarker detection

O'Reilly, Emmet J. and Conroy, Paul J. and Hearty, Stephen and Keyes, Tia E. and O'Kennedy, Richard and Forster, Robert J. and Dennany, Lynn (2015) Electrochemiluminescence platform for the detection of C-reactive proteins : application of recombinant antibody technology to cardiac biomarker detection. RSC Advances, 5 (83). pp. 67874-67877. ISSN 2046-2069

[img]
Preview
Text (O'Reilly-etal-RSCA2015-Electrochemiluminescence-platform-for-the-detection-of-C-reactive-proteins)
O_Reilly_etal_RSCA2015_Electrochemiluminescence_platform_for_the_detection_of_C_reactive_proteins.pdf
Accepted Author Manuscript

Download (661kB) | Preview

Abstract

This work exploits the high-affinity of recombinant antibodies and low background electrochemiluminescence (ECL) for cardiac-biomarker detection. The developed assay is capable of fg mL-1 detection limits as well as the detection of C-Reactive Protein (CRP) over a clinically relevant range. The assay demonstrated robust reproducibility, selectivity and stability while also highlighting a novel platform for detection of cardiac biomarkers at low concentrations.